Blog

Revolutionary Antibody Storage: No More Cold Chains
🔬 The future of antibody storage is here! 🌡️ Say goodbye to cold-chain dependency with Upkara's BioFix™ technology. ❄️💡🚀💪

Swiss Vaccine Developer Wins $22m Grant to Tackle Global Gonorrhea Crisis
🔬 Swiss vaccine developer LimmaTech Biologics AG receives $2.2m grant from CARB-X to fight Neisseria gonorrheae. 💉

Discovering Nature’s Secrets for Powerful Medicines
🔍 Scientists are exploring nature for improved biopharmaceuticals, even as bioprocessing evolves. 🌿🔬 Exciting discoveries in forest fungi and oceanic sources hold promise. 🍄💊🌊

Revolutionizing Vaccines: Innovation and Flexibility are Vital
🌍💉 The vaccine sector needs innovative technology and regulatory flexibility to thrive, says industry group Vaccines Europe. 💪🔬🚀✨

Breakthrough: Tobacco Plants Produce Vaccine Boosters
🌱🌿 Researchers have found a way to produce the vaccine adjuvant QS-21 in tobacco plants, solving supply shortages. 💉🌳🔬 vaccines biotechnology

Revolutionary Cell-Therapy Tech: Scalability Made Simple
🔍 MFX is revolutionizing cell therapy manufacturing with its scalable Cyto Engine Stack, securing funding for a 2025 release. 🧪📈💰🔬

Revolutionizing Cell and Gene Therapy: Challenges and Opportunities
Redefining Cell and Gene Therapy Navigation 📰 explores the challenges and opportunities in this rapidly evolving sector 🧬. It emphasizes the need for improved regulatory frameworks and collaboration 💼💪🏼🌍.

Fast-Cat: AI Lab Revolutionizes Catalysis Research
🤖 Scientists have developed an AI-based self-driving lab called Fast-Cat for catalysis research. 🧪⏱️ It provides in-depth analyses and accelerates discovery.

BMS to Build $400M Biologics Facility in Dublin Boosting Manufacturing Capacity
📢 Bristol Myers Squibb (BMS) invests $400M in a new sterile drug product facility in Dublin, Ireland. 🌍💪🧪🔬 Expected completion: 2026.






